Physician profile
Matthew Amarante
NPI 1811230089
$8,924.85
in general payments reported to CMS, 2019-2025
11 companies · $2,180 in 2025
The $2,180 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $245 · 2021: $2,053 · 2022: $1,154 · 2023: $1,819 · 2024: $1,473 · 2025: $2,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,601 · Travel and Lodging: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,601.46 |
| Travel and Lodging | $870.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,704.43 | 2021-2025 | Proclaim, Eterna, Infinity |
| Medtronic, INC. | $2,008.14 | 2021-2025 | Mazor X System, Intellis Adaptivestim, Synchromedii |
| Baxter Healthcare | $541.07 | 2020-2023 | Actifuse |
| Boston Scientific Corporation | $474.10 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $255.70 | 2021 | |
| Globus Medical, INC. | $251.41 | 2022-2024 | Hedron Ia |
| Depuy Synthes Sales INC. | $189.86 | 2020-2021 | |
| Providence Medical Technology, INC. | $136.62 | 2021 | |
| Stryker Corporation | $135.45 | 2021 | |
| Sanara Medtech INC. | $118.85 | 2025 | Celleraterx |
| Biotronik Nro, INC. | $109.22 | 2024 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Amarante listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.